|
|
Volumn 102, Issue 4, 2010, Pages 219-
|
|
StatBite: FDA oncology drug product approvals in 2009.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
10-PROPARGYL-10-DEAZAAMINOPTERIN;
AMINOPTERIN;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CETUXIMAB;
DEPSIPEPTIDE;
DRUG DERIVATIVE;
EVEROLIMUS;
GLUTAMIC ACID DERIVATIVE;
GUANINE;
MAGNETITE;
MONOCLONAL ANTIBODY;
OFATUMUMAB;
PANITUMUMAB;
PAZOPANIB;
PEMETREXED;
PRALATREXATE;
PYRIMIDINE DERIVATIVE;
RAPAMYCIN;
ROMIDEPSIN;
SULFONAMIDE;
ARTICLE;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INJECTION;
ORAL DRUG ADMINISTRATION;
UNITED STATES;
ADMINISTRATION, ORAL;
AMINOPTERIN;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DEPSIPEPTIDES;
DRUG APPROVAL;
FERROSOFERRIC OXIDE;
GLUTAMATES;
GUANINE;
HUMANS;
INJECTIONS;
PYRIMIDINES;
SIROLIMUS;
SULFONAMIDES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 77949342576
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djq030 Document Type: Article |
|
Times cited : (35)
|
|
References (0)
|